Edesa Biotech (EDSA) Earnings Date & Reports

Get AI intraday signals

A.I. Advisor

published Earnings

EDSA is expected to report earnings to rise 56.70% to -15 cents per share on December 13

Edesa Biotech EDSA Stock Earnings Reports

Q3'23

Est.

$-0.16

Q2'23

Beat

by $0.06

Q1'23

Est.

$-0.12

Q4'22

Beat

by $0.05

Q3'22

Beat

by $0.03

The last earnings report on August 11 showed earnings per share of -10 cents, beating the estimate of -15 cents. With 23.94K shares outstanding, the current market capitalization sits at 5.72M.

View a ticker or compare two or three

Compare

EDSA

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For EDSA
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a biopharmaceutical company, which focuses on acquiring, developing and commercializing clinical stage drugs for dermatological and gastrointestinal indications with clear unmet medical needs.

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

100 Spy Court

Phone

+1 289 800-9600

Employees

Web

https://www.edesabiotech.com